295 results about "Apigenin" patented technology

The present invention includes 1) a novel formulation for the treatment of hair loss comprising oleanolic acid (a 5α-reductase inhibitor), apigenin (a vasodilator), and biotinyl-GHK (a cell metabolism stimulant), 2) a novel additive for the treatment of hair loss comprising oleanolic acid, apigenin, biotinyl-GHK and a delivery agent, 3) a personal care, cosmetic, and/or dermopharmaceutical composition comprising oleanolic acid, apigenin, biotinyl-GHK, and at least one additional ingredient, and 4) a method for treating hair loss comprising the administration of oleanolic acid, apigenin, and biotinyl-GHK.

Personal care composition comprising at least one hair growth regulating compound selected from the group consisting of glyceryl dilaurate, apigenin, tetrahydrocurcumin, oleanolic acid, azelaic acid, sulforaphane, canavanine, pyridoxal 5-phosphate, phytic acid, tannic acid, grape seed extract, NG-nitro-L-arginine-methyl ester, benzamidine, sodium butyrate, betulinic acid, polyornithine, polyarginine, fisetin, jasmonates, methyl-jasmonate, cis-jasmone, caffeic acid phenethyl ester, delphinidin, ethyl abietate, esculetin, sorbic acid methyl ester, canaline, N-formyl-methionine, N-formyl-alanine, taurine, palmitoyl carnitine, undecanol, undecylenic acid, rutin, fusidic acid, phenyl pyruvic acid, L-isoleucine, phenyl glycine, silibinin, silymarin, L-ascorbic acid-6-palmitate, N-undecylenoyl-L-phenylalanine, and salts, derivatives and mixtures of any of the foregoing; and a dermatologically-acceptable carrier.

The invention relates to a plant active component composition with slow anti-allergic action. The plant active component composition is mainly prepared from natural plant active components: 0.1-5wt% of glycyrrhetinic acid, 0.05-1wt% of apigenin, 0.05-1% of table gallic catechin gallic acid ester, 0.1-3wt% of asiaticoside, 0.1-5wt% of baicalin and 0.1-10wt% of fucus serratus extract. The composition is used for preparing cosmetics or personal care products with a plurality of effects of resisting skin allergy, diminishing inflammation, relieving itching, resisting oxidation, moisturizing and the like. The composition is safe and free of toxic and side effects, and can be compounded with a plurality of components, sensitive skin and dry skin are effectively improved, and the barrier function of the skin is reinforced.

A UGT2B inhibitor capable of increasing the bio-availability of a drug, is a compound in a free base or a pharmaceutically acceptable salt form that is selected from the group consisting of: capillarisin, isorhamnetin, β-naphthoflavone, α-naphthoflavone, hesperetin, terpineol, (+)-limonene, β-myrcene, swertiamarin, eriodictyol, cineole, apigenin, baicalin, ursolic acid, isovitexin, lauryl alcohol, puerarin, trans-cinnamaldehyde, 3-phenylpropyl acetate, isoliquritigenin, paeoniflorin, gallic acid, genistein, glycyrrhizin, protocatechuic acid, ethyl myristate, umbelliferone, PEG (Polyethylene glycol) 400, PEG 2000, PEG 4000, Tween 20, Tween 60, Tween 80, BRIJ® 58, BRIJ® 76, Pluronic® F68, Pluronic® F127, and a combination thereof. A UGT2B enhancer capable of enhancing a clearance rate of morphine-like analgesic agents, is a compound in a free base or a pharmaceutically acceptable salt form that is selected from the group consisting of: nordihydroguaiaretic acid, wogonin, trans-cinnamic acid, baicalein, quercetin, daidzein, oleanolic acid, homoorientin, hesperetin, narigin, neohesperidin, (+)-epicatechin, hesperidin, liquiritin, eriodictyol, formononetin, quercitrin, genkwanin, kaempferol, isoquercitrin, (+)-catechin, naringenin, daidzin, (−)-epicatechin, luteolin-7-glucoside, ergosterol, rutin, luteolin, ethyl myristate, apigenin, 3-phenylpropyl acetate, umbelliferone, glycyrrhizin, protocatechuic acid, poncirin, isovitexin, 6-gingerol, cineole, genistein, trans-cinnamaldehyde, and a combination thereof.

The invention discloses an effective part of stevia and the activity and the application thereof. The effective part mainly comprises stevioside category and flavone category which are obtained by extracting and separating from dried stevia leaves, wherein the sum of the percentage content of the stevioside components in the stevioside part is 5 to 100 percent (w/w), and the stevioside components mainly contains the stevioside, stevibioside, rebaudioside A, B, C, D, E, and F, dulcoside A and the derivative thereof, etc.; the sum of the percentage content of the flavone components in the flavone part is 5 to 100 percent (w/w), and the flavone components mainly contains luteolin, quercetin, luteolin-7-O-Beta-D-glucoside, apigenin-7-O-Beta-D-glucoside, quercitrin, quercetin-3-O-Beta-D-arabinoside, quercetin-3-O-(4-O-anti form-caffeoyl acyl-Alpha-L-rhamnose-(1 to 6)-Beta-D-galactoside) and the derivative thereof, etc., and 4, 5-dicaffeoylquinic acid and the derivative thereof, etc. The effective part has significant sugar-reducing and fat-reducing effects, can be used singly or combined with any other Chinese medicines and Western medicines or foods in any proportion, is used for preparing medicines or functional foods, and is used for treating hyperglycemia and hyperlipoidemia.

The present invention provides an apigenin vesiculation preparation and its preparation process. Said preparation composition includes (by wt%) 0.25%-20% of apigenin, 40%-90% of non-ionic surface active agent, 8.7-48.8% of cholesterol and 2%-20% of lyophilization protection agent. The described non-ionic surface active agent can be Span-20, Span-40, Span-60, Span-80, Tween-20, Tween-60, Tween-80, benzozir, maizir, poloxamer or their mixture. Said invention can be made into preparations of injection, nose drops, ointment and oral liquor, etc, and can be prepared by adopting ethyl alcohol injection method, film dispersion method, inversed phase evaporation method, hydration method, extrusion method, mechanical method and pH gradient method.

The invention relates to a method for preparing apigenin, which comprises the following steps: after screening and pulverizing celery seeds, placing the celery seeds into an alcohol container with the content of 70 percent, stirring the celery seeds and then leading the celery seeds to stand; after fusing the powdery celery seeds and alcohol, changing the powdery celery seeds into a granular mixture; extracting the granular mixture in the container for three times, the time interval of extraction each time is two hours; filtering the extracted granules by a solution and decompressing and concentrating the extracted granules so as to prepare the powdery refined apigenin, wherein the purity of the extracted refined apigenin is 98 percent. The method is used for preparing the powdery apigenin and oily deep sea fish oil and placing the powdery apigenin and the oily deep sea fish oil into a capsule, and each capsule has the weight of 500 mg after raw material are proportioned and comprises 150 mg-200 mg of apigenin and 300 mg-350 mg of deep sea fish oil. The invention has the effects of regulating the blood pressure and the blood fat, resisting the oxidation, improving the immunity, delaying the aging, and the like.

The invention relates to the field of biological medicine and specifically relates to a compound for hormonous dermatitis, a preparation, a preparation method and an application thereof. The compound comprises the following components: rose hydrosol, grape seed extract, aloe vera gel, liquorice extracting solution, curcumin, apigenin, oat-beta-glucan, amidogen glucan, water-soluble azone, polylysine, water soluble vitamin E, buxus chinensis, 1,2-glutaraldehyde, compound growth factor, hydroxypropyl-beta-cyclodextrin, EDTA-2Na, collagen, humectants, auxiliary material and natural preservatives. The components in the compound have mild action to skin and are free from irritation; the components are collocated with each other, can prevent inflammation and anaphylaxis caused by hormonous dermatitis on the basis of supplying moisture preservation and can restrain bacteria to infect the damaged skin. The added compound growth factor can promote metabolism and repairing of cells of corium layer, epidermis and especially cuticle and can promote the forming of intercellular substance, so as to repair the damaged skin and achieve the effects of protection and curing.

The invention provides a method for extracting apigenin from Chinese violet, which greatly improves the yield and the purity of the apiolin. A set of following procedures is provided for extracting and separating high-purity apiolin from the Chinese violet: processing ultrasonically while adopting alcohol extract, centrifugating, concentrating, extracting, performing adsorption chromatography by using macroporous absorption resin LSA-10 and chromatographic column silica gel, continuously separating, concentrating, and crystallizing by acetone to obtain the pure apigenin. The integral separation process has low requirement on environment conditions, the separation time is shorter and the purity is high. Separating materials are easy to obtain and cheap, the separation operation process is simple and easy to control, and the purifying efficiency is high by adopting crystallization and recrystallization.

The invention discloses a callicarpa nudiflora effective part extract with a hemostatic effect and a preparation method of a pharmaceutical preparation of the callicarpa nudiflora effective part extract. The effective part extract and the pharmaceutical preparation contain total flavonoids of the callicarpa nudiflora and are extracted and separated from the callicarpa nudiflora which is a traditional Chinese medicine plant, the content of the total flavonoids is not less than 50%, and the effective part extract and the pharmaceutical preparation mainly contain galuteolin, luteolin-3'-O-beta-D-glucopyranoside, luteolin-4'-O-beta-D-glucopyranoside, calliterpenone, luteolin, apigenin and cosmosiin. The effective part extract and the pharmaceutical preparation have significant hemostatic effects.

The invention provides a method for separating and purifying flavonoid glycoside compounds in lotus plumules. The method comprises the following steps of 1 preparing of a lotus plumule solution, 2 enrichment of lotus plumule total flavonoids and 3 separating and purifying through high-speed countercurrent chromatography, and quercetin-3-O-beta-D-glucoside, isorhanetin-3-O-beta-D-glucoside, apigenin-6-C-beta-D-xylose-8-C-beta-D-glucoside and apigenin-6-C-beta-D-glucose-8-C-beta-D-glucoside are obtained. The flavonoid glycoside compound monomers separated and purified through the method are high in purity, low in loss, easy to operate, high in preparation quantity, economical and environmentally friendly.

Apigenin is a nontoxic compound. The present invention is appropriate for apigenin use in people who have a high risk of getting cancer, and in people who have cancer through chemoprevention and chemotherapy, respectively. We showed that apigenin inhibited cancer cell proliferation, tumor growth and angiogenesis. Apigenin selectively inhibited proliferation and induced apoptosis of cancer cells, enhanced the sensitivity of different cancer cells to different therapeutic drugs including cisplatin and taxol. Apigenin also inhibits angiogenesis and tumor growth in human cancers, and inhibits angiogenic inducers such as hypoxia-inducible factor 1 (HIF-1) and vascular endothelial growth factor (VEGF). Apigenin inhibited expression of HIF-1 and VEGF through PI3K, AKT, p70S6K1 and HDM2 pathways, which are commonly observed in all kinds of human cancers. Thus, our results indicate that apigenin can be applied to various human cancers for chemoprevention, and for chemotherapy when combined with other therapeutic reagents.

An apiin derivative, its production, medicinal composition containing it and its usage in treatment of diabetes and its complication are disclosed. It can also be used to prepare hypoglycemic, hypolipidemic and cholesterol-lowering medicines with aldose reductase activity inhibiting function.

The invention relates to a kind of natural medicine of broad spectrum antibiotic. At present, the broad spectrum antibiotic medicine with high effect and safety is at shortage all round the world. The invention is intended to extract laminarinsulphate or sulphonic acid sugar ester or sulphosalts from plant chickweed or other chickweed plant with two resin adsorption methods or a water extraction and alcohol precipition method. The spectrum antibiotic in the invention is distributed under 50,000 in the formula weight formed by carbon glycosidic bond and/or oxide glycosidic bond with phenol, especially the total flavones comprising apigenin. However, the invention mainly acts as total phenolic glycoside with the formula weight under 4,000. Besides, the invention can form brownish compound with the total flavones comprising apigenin and the glycosidic ingredients without sulfur element, so as to be applied as broad spectrum antibiotic drug. Therefore, the compound in the invention can be applied to cure ADIS virus, hepatitis virus, influenza virus and parainfluenza virus comprising SARS, adenovirus, verruca acuminate virus, enterovirus, mumps virus, herpes simplex virus, herpes zoster virus and varicella. No toxic effect has been found in the application. What is more, the invention can be made into 10 sorts of formulation, disinfector and health-improving products.

The invention provides a method for composite enzymolysis-assisted extraction of an active ingredient from propolis, and belongs to the extraction technology of propolis. The method comprises the following steps of: selecting high-quality rough propolis as a raw material; removing impurities, refrigerating, crushing and then homogenously mixing a certain amount of enzymolysis agent; filling the mixed raw material on a biological enzymolysis bed; performing biological enzymolysis by adjusting parameters such as enzymolysis temperature, humidity, pH, time and the like; extracting flavonoid from the propolis in a classified way in an extraction tank by controlling factors such as alcoholic strength, solid-to-liquid ratio, temperature, pressure, time and the like; and performing reduced pressure distillation by controlling concentration temperature and vacuum degree to remove impurities and moisture. The method has the obvious advantages that: 1, a propolis enzymolysis technology and a propolis alcohol extraction technology are integrally applied to production practice, and the method has a simple process and an accurate technological parameter range and is easy in realization of industrialization; 2, the contents of flavone aglycones such as myricetin, quercetin, apigenin, pinocembrin and the like in extracted active ingredient of the propolis are increased; and 3, the antioxidative activity of a propolis enzymolysis product can be obviously improved.

Disclosed is a novel use of apigenin as a chondroregenerative agent, which has the effects of reducing elevated of cartilage destruction markers including total synovial fluid volume and proteoglycan, total proteins and prostaglandin in a synovial fluid, improving the condition of synovial cells, and regenerating cartilage. Also, the present invention discloses a therapeutic agent for osteoarthritis comprising apigenin as an agent regenerating articular cartilage, and a method of treating osteoarthritis using such a therapeutic agent.

The invention relates to a total flavone c-glycoside effective component extract separated from traditional Chinese medicine abrus mollis hance, belonging to natural medicine technical field, which mainly contains apigenin-6, 8-bis-C-glucoside, apigenin-6-C-glucose-8-C-arabinfuranoside and apigenin-6-C-arabinose-8-C-glucoside, whose flavone c-glycoside content is higher than 40%. The invention relates to an extraction method of the total flavone c-glycoside effective component extract. Pharmacodynamic tests prove that the abrus mollis hance total flavone c-glycoside extract can be used as active component to prepare the drugs for the prevention and treatment of acute and chronic hepatitis or the like.

Hair care compositions including from about 0.005% to about 5% apigenin; from about 0.15% to about 12% of a solubilizing agent, wherein the solubilizing agent comprises an amine functional group; and at least about 20 weight percent of an aqueous carrier, where the composition has a pH ranging from about 3 to about 10, and methods of making the same are provided. These hair care compositions can be applied to any area of the scalp or hair where healthier hair appearance is desired.

The invention discloses a method for separating and extracting apigenin, acacetin-7-O-beta-D-glucoside and apigenin-7-O-beta-D-glucoside from dendranthema indicum, which belongs to a method for extracting chemical substances from a natural plant. The method is sequentially carried out according to the following steps of: 1. extract preparation; 2. extraction: sequentially extracting the extract of the dendranthema indicum by using petroleum ether, chloroform and ethyl acetate; and 3. separation and extraction: (1) carrying out normal-pressure and reduced-pressure silica column chromatography on the extracted part by using the ethyl acetate; and (2) separating fractions through a semi-preparative high-efficiency liquid chromatographic instrument to obtain the acacetin-7-O-beta-D-glucoside, the apigenin-7-O-beta-D-glucoside and the apigenin as compounds. In the method, the semi-preparative high-efficiency liquid chromatographic instrument is directly adopted for separation to obtain the three compounds after silica column chromatography is adopted, and the method has good separation effect, short time, high product purity and less environmental pollution.

This invention relates to the topical treatment of the Carpal Tunnel Syndrome by the use of a selected protein kinase C inhibitor and an effective penetrating agent selected from lecithin organogel or poloxamer 407 lecithin organogel. The protein kinase C inhibitors may be selected from sphingosine, sphinganine, phytosphingosine, curcumin, tetrahydrocurcumin, curcuminoids or apigenin.

The invention discloses an apigenin polylactic acid sustained release microsphere and a preparation method of the apigenin polylactic acid sustained release microsphere. The preparation method comprises the following steps: dissolving hydroxyl-terminated racemic polylactic acid and soybean lecithin in an organic solvent; stirring the liquid, and slowly adding the apigenin mixed liquid subjected to ultrasonic treatment in an emulsifier aqueous solution to be emulsified; reducing the pressure, removing the solvent with steam, concentrating the volume; centrifuging at high speed, washing and drying the obtained mixed liquid to prepare the polylactic acid entrapped apigenin acid sustained release microsphere, wherein the microsphere particle size is 1-5 microns, the drug loading ratio is larger than 25%, the encapsulation efficiency is larger than 79%, and the sustained release time is more than 550 hours. According to the polylactic acid with good biocompatibility and biodegradability is taken as a clad material to prepare the apigenin polylactic acid sustained release microsphere, so that the microsphere is uniform in shape, smooth and adhesion-free on the surface, uniformly distributed in the particle size, and good in slow-release effect, can keep continuous release time in vitro 550 h above, conquers the defects that the drug is poor in water solubility and fat solubility, improves the oral administration availability, prolongs the drug action time and improves the drug therapeutic effect.

The invention discloses a drug carrier of apigenin and a preparation method. The drug carrier is micro-emulsion prepared by mixing sodium deoxycholate, sucrose stearate, isopropyl alcohol, ethyl acetate and a sodium chloride water solution. The drug carrier disclosed by the invention takes the ethyl acetate as an oil phase and the apigenin has highest anti-oxidization activity and maximum accumulative releasing rate.

The invention discloses a preparation method of sephadex surface apigenin molecular engram sorbing material as well as the application of the sephadex surface apigenin molecular engram sorbing material to selective adsorption separation of apigenin molecules in the analysis of foods and medicine. In the method, sephadex is taken as a support, and apigenin molecular engram polymer is decorated on the surface of the sephadex. The invention is characterized in that apigenin, acrylamide, ethylene-glycol dimethyl acrylate, azodiisobutyronitrile and acylation sephadex are added in a certain proportion; and in the medium of furanidine, argon gas is used to remove oxygen, an reaction lasts for 20 to 30 h in thermostatic water bath at the temperature of 60 to 65 DEG C, and then filtering and washing are performed. Acetic acid and methanol solution with the volume fraction of 12 to 18 percent is used for Soxhlet extraction for 12 to 22 h so as to remove apigenin template molecules, and then the material is obtained through washing and drying. The invention has the advantages that a specific recognition capability to apigenin molecules is achieved, the selectivity is high, the adsorbing speed is fast, the adsorbing performance is excellent, the biological degradation is achieved, the process is simple, and regeneration capability and environmental protection are achieved.

The invention discloses an apigenin-carrying hyaluronic acid targeted nano assembly and a preparation method thereof. The system is composed of hydrophilic polysaccharide sodium hyaluronate and a hydrophobic drug namely apigenin. During preparation, firstly, sodium hyaluronate and apigenin powder are fully ground in a grinding bowl; then, the mixed powder is taken to mix with distilled water, and a primary nano suspension is obtained by stirring; and finally, ultrasonic treatment is performed with an ultrasonic cell crusher to obtain the apigenin-carrying hyaluronic acid targeted nano assembly. The drug carrier system disclosed by the invention significantly improves the dissolution rate of a drug and has good physical stability. The other outstanding advantage of the drug carrier system is that the particle size is small, the average particle size is less than 200nm, and passive targeting can be realized by virtue of an EPR (electron paramagnetic resonance) effect of a tumor location. Meanwhile, hyaluronic acid is taken as a carrier, so that the apigenin-carrying hyaluronic acid targeted nano assembly can realize active targeting, reduce toxic and side effects, and improve the treatment efficiency of an antitumor drug.

The invention belongs to the field of pharmacy, and provides application of three flavone glycoside compounds luteolin-7-O-[alpha-L-rhamnose-(1->2)]-beta-D-glucoside (trivial name is lonicerin), apigenin-7-O-[alpha-L-rhamnose-(1->2)]-beta-D-glucoside (trivial name is rhoifolin) and luteolin-6-C-beta-D-glucose-8-C-beta-D-xyloside in preparing medicament or health-care food for preventing and treating hepatitis.